The global oligonucleotide synthesis market is expected to foresee significant growth. North America leads the growth!
- Vikas Kumar
- January 14, 2023
- HEALTHCARE, NEWS
- Asia oligonucleotide synthesis market, Europe oligonucleotide synthesis market, Middle east oligonucleotide synthesis market, oligonucleotide synthesis, oligonucleotide synthesis market, oligonucleotide synthesis market analysis, oligonucleotide synthesis market forecast, oligonucleotide synthesis market growth, oligonucleotide synthesis market share, oligonucleotide synthesis market size, oligonucleotide synthesis market trend, US oligonucleotide synthesis market
- 0 Comments
The global oligonucleotide synthesis market is expected to grow at a significant rate of around 12% during the forecast period. The synthesis of oligonucleotides can be used for a lot of things, like sequencing DNA, making artificial genes, and diagnosing a lot of diseases that are caused by genetic mutations. The oligonucleotide synthesis market is being driven by some major factors, including advancements in the synthesis of oligonucleotides and expanding research efforts in the synthetic and biological fields. The new microchip-based oligonucleotide synthesis and the increasing prevalence of DNA microarray technology in the use of oligonucleotides for diagnostic and therapeutic purposes are expected to boost the growth of the global oligonucleotide synthesis market during the forecast period.
The expanding research activities and partnerships of numerous pharmaceutical companies and research institutes are driving the oligonucleotide synthesis market. For instance, in 2017, CordenPharma International and GE Healthcare Dharmacon Inc. entered into a agreement to develop a complete oligonucleotide-based drug discovery system. In addition, the oligonucleotide synthesis market is anticipated to expand during the forecast period due to a decrease in sequencing costs and the development of novel methods.
Request for a sample of the report browse through- https://univdatos.com/report/oligonucleotide-synthesis-market/
Based on product, the market is segmented into oligonucleotide synthesis products, synthesized oligonucleotides, reagents, and others. Among these oligonucleotide synthesis products category is to witness the fastest CAGR during the forecast period owing to the growing number of FDA-approved drugs and extensive clinical pipeline of oligonucleotide-based drugs. For instance, in December 2021, U.S. FDA granted IND status for individualized antisense oligonucleotide drug products for severely debilitating or life-threatening diseases.
On the basis of application, the market is categorized into DNA sequencing and amplification (PCR), diagnostics, therapeutics, and others. Among these, DNA sequencing and amplification (PCR) to hold a significant share of the market in 2020. This is mainly due to the rising demand for DNA sequencing for diagnostic purposes for various chronic diseases.
For a detailed analysis of the Global Medical Device Outsourcing Market browse through– https://univdatos.com/get-a-free-sample-form-php/?product_id=30936
For a better understanding of the market adoption of the oligonucleotide synthesis market, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to hold a significant share in the market in 2020. This is mainly due to the rising funds being invested in manufacturing companies and academic and research institutions for the development of gene synthesis-based products like precision medicine and other treatments. For instance, as per National Center for Biotechnology Information (NCBI), synthetic biology research and development receives approximately US$220 million annually from the US government.
Some of the major players operating in the market include Danaher Corporation, Twist Bioscience Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies Inc., GE Healthcare, LGC Biosearch Technologies, Bio-synthesis Inc., Biotage.
Global Medical Device Outsourcing Market Segmentation
Market Insight, by Product
- Oligonucleotide Synthesis Products
- Synthesized Oligonucleotides
- Reagents
- Others
Market Insight, by Application
• DNA Sequencing and Amplification (PCR)
• Diagnostics
• Therapeutics
• Others
Market Insight, by End-User
- Research Institutes
- Diagnostic Laboratories
- Pharmaceuticals Industries
- Biotechnology Companies
- Others
Market Insight, by Region
- North America
- US
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Rest of the World
Top Company Profiles
- Danaher Corporation
- Twist Bioscience Corporation
- Merck KGaA
- Eurofins Scientific SE
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- GE Healthcare
- LGC Biosearch Technologies
- Bio-synthesis Inc.
- Biotage
Related Posts
